Could this medicine revolutionise schizophrenia treatment?

Working on a new mechanism of action, this treatment could change the lives of patients with schizophrenia. But not all patients can take it.

How will post-lockdown restrictions impact pharmacists?

After more than 100 days in lockdown, New South Wales pharmacists reflect on the challenges of the past few months and what lies ahead.

Acute care opioid prescribing overhauled

A new standard of care will help to prevent long-term reliance on opioid analgesics used for acute pain.

Oxybutynin for hot flashes when hormones can’t be used

Can oxybutynin be useful for some patients who are unsuited for hormonal pharmacotherapy? Some people might describe hot flashes as an unannounced and brief...

Over 30% increase in asthma deaths in one year

The significant rise in Australian asthma deaths is cause for immediate and widespread concern. Here’s what experts say needs to change.

Efficacy and safety of diclofenac for the management of pain

Pharmacists are well equipped to assist patients who request treatment for pain. This article discusses the role of the pharmacist in the appropriate supply of over-the-counter diclofenac for management of pain.